The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
April 25th 2025
New research reveals how high blood sugar from type 2 diabetes alters brain function, mimicking early Alzheimer symptoms and impacting memory.
Study: Menopause Possible to Blame for Increased Forgetfulness, Lack of Attention
January 18th 2021Multiple large-scale studies have suggested that menopause is a sex-specific risk factor for cognitive dysfunction independent of aging and other menopause symptoms, such as depression, anxiety, and hot flashes.
Read More
Walgreens’ Plans to Provide COVID-19 Vaccine Access in Medically Underserved Communities
January 18th 2021Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on Walgreens’ plans to provide access to COVID-19 vaccines among vulnerable populations in medically underserved communities.
Watch
How President-elect Biden’s Cabinet Nominations May Impact Pharmacy This Year
January 16th 2021Pharmacy Times® interviewed Chad Landmon, the chair of intellectual property and FDA practice groups at Axinn, Veltrop & Harkrider, on the potential impact President-elect Joseph Biden’s cabinet nominations may have on the pharmacy field in 2021.
Watch
ISMP Provides Recommendations for Avoiding COVID-19 Vaccination Administration Errors
January 15th 2021The recommendations focus on dilution errors, vaccine and monoclonal antibody mix-ups, waste of doses, administering immunizations to the wrong age group, errors with scheduling the second dose, and allergic reactions.
Read More
APhA: Biden $1.9 Trillion COVID-19 Plan is Strong Start to Recovery From Pandemic
January 15th 2021In a statement by the APhA, Scott J. Knoer, executive vice president and CEO of APhA, noted the association’s support for this first step by the Biden administration on the road to recovery from the pandemic.
Read More
Interim Results of Johnson & Johnson Single-Dose COVID-19 Vaccine Shows 90% Efficacy
January 15th 2021The single dose investigational vaccine being developed by the Janssen Pharmaceutical Companies of Johnson & Johnson is a recombinant, replication-incompetent adenovirus serotype 26 vector encoding a stabilized SARS-CoV-2 spike protein.
Read More
Study: Increasing Exercise During First Trimester May Reduce Gestational Diabetes Risk
January 14th 2021The analysis found that at least 38 minutes of moderate intensity exercise each day was associated with the lower risk, which is a little more than the current recommendations of at least 30 minutes a day, 5 days a week.
Read More
Study: Higher Vaccine Rates Associated with Indicative Language by Provider, More Efficient
January 14th 2021The new research shows that adolescents are 9 times more likely to receive a vaccine when providers introduce the topic to parents with a simple statement such as “your child is due for vaccines today,” as it results in a shorter vaccine discussion.
Read More
Study: Initial Severity of COVID-19 Not Associated with Later Respiratory Complications
January 14th 2021Liam Townsend, MD, and his co-authors looked at a number of measures of recovery for 153 patients who were followed in an outpatient clinic a median of 75 days after their COVID-19 diagnoses.
Read More
Anticipating Problems During First Wave of COVID-19 Vaccinations
January 14th 2021Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on whether any unforeseen problems have arisen during the first wave of COVID-19 vaccinations at long-term care facilities.
Watch